Topical Antifungal Treatment for Tinea Cruris

Medicis Global Service

Status and phase: Completed; Phase 3

Conditions: Tinea Cruris

Treatments: Drug: Placebo; Drug: 33525

Study type: Interventional

Funder types: Industry

Identifiers

NCT01342315

MP-1000-01

Details and patient eligibility

About

To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris

Enrollment: 483 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• moderate erythema, mild scaling, and moderate pruritis

Exclusion criteria

• pregnancy and allergies

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

483 participants in 2 patient groups

Active

Experimental group

Description:

Product 33525

Treatment:

Drug: 33525

Placebo

Experimental group

Description:

Product 33525 Placebo

Treatment:

Drug: Placebo